Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

A bill filed in Springfield would allow doctors to prescribe some HIV medication without needing prior authorization.

The National Agency for the Control of AIDS has described information in sections of the media regarding the withdrawal of ...